Research map: Cost-effectiveness analysis of emicizumab use in hospitalized older individuals with acquired hemophilia A

Back to the article

Papers in this map

  1. Acute Groin Pain Revealing Acquired Hemophilia A: A Case Report of Spontaneous Iliopsoas Hematoma · Sara Senne · 2026 · Cites this paper
  2. Abnormal whole-blood viscoelastic test results in patients with bleeding disorder of unknown cause · 2026 · Related
  3. Doxycycline for Epistaxis in Hereditary Hemorrhagic Telangiectasia: Genotype-Stratified Outcomes · 2026 · Related
  4. Sirolimus Outperforms Alpelisib in Models of NRASQ61R-Driven Vascular Overgrowth · 2026 · Related
  5. Tryptophan metabolism reprogramming potentially contributes to the prothrombotic milieu in mice and humans with SARS-CoV-2 · 2026 · Related
  6. NETs contribute to acute episodes but not ADAMTS13 relapses in immune-mediated thrombotic thrombocytopenic purpura · 2026 · Related
  7. VLX-1005, but not argatroban, prevents ITAM-mediated platelet activation and heparin-induced thrombocytopenia · 2026 · Related
  8. Successful eltrombopag discontinuation in paraneoplastic immune thrombocytopenia: a case report · 2026 · Related
  9. Alpelisib, a PI3Kα inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypes · 2025 · Related
  10. Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 study · 2026 · Related
  11. Interactions of dual antiplatelet and anticoagulant with C1q and FH regulate complement activation by injured cells · 2026 · Related

Source: OpenAlex (CC0)